Trial of CUDC-907 in Children and Young Adults With Relapsed or Refractory Solid Tumors, CNS Tumors, or Lymphoma
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02909777 |
Recruitment Status :
Active, not recruiting
First Posted : September 21, 2016
Last Update Posted : March 12, 2024
|
Sponsor:
Dana-Farber Cancer Institute
Collaborator:
Curis, Inc.
Information provided by (Responsible Party):
David S Shulman, MD, Dana-Farber Cancer Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | July 2024 |
Estimated Study Completion Date : | July 2024 |